Perioperative Rates of Incidental Prostate Cancer after Aquablation and Holmium Laser Enucleation of the Prostate
Urologia Internationalis · 2024
DOI: 10.1159/000539014 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Urologia Internationalis, 2024. Verfasst von Simon Gloger und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Minimally Invasive and Robotic Urology, Augusta Hospital Bochum, Witten/Herdecke University, Bochum, Germany. Hauptthemen laut MEDLINE: Lasers, Solid-State, Prostatic Neoplasms, Incidental Findings, Prostatic Hyperplasia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Aquablation and holmium laser enucleation of the prostate (HoLEP) have evolved as established therapeutic options for men with benign prostatic obstruction (BPO). We sought to compare the rates of incidental prostate cancer (iPCa) after aquablation and HoLEP.
Methods
At our center, between January 2020 and November 2022, 317 men underwent aquablation, and 979 men underwent HoLEP for BPO. Histopathological assessment of resected tissue was conducted in all cases. If iPCa was detected, the Gleason score and percentage of affected tissue were assessed. Differences in important predictive factors for prostate cancer between study groups were accounted for by additional matched pairs analysis (with matching on age ± 1 year; PSA ± 0.5 ng/mL; and prostate volume ± 5 mL).
Results
Histopathology revealed iPCas in 60 patients (4.6%): 59 (6.03%) after HoLEP and 1 (0.3%) after aquablation (p = 0.001). Of 60 of incidental cancers, 11 had a Gleason score ≥7 (aquablation: 1/1 [100%]; HoLEP: 10/59 [16.9%]). The aquablation and HoLEP study groups differed in patient age, preoperative PSA, and prostate volume. Therefore, matched pairs analysis (aquablation: 132 patients; HoLEP: 132 patients) was conducted to improve comparability. Also after the matching procedure, significantly fewer iPCas were diagnosed after aquablation than HoLEP (aquablation: 0 [0%]; HoLEP: 6 [4.5%]; p = 0.015).
Conclusion
Significantly fewer iPCas were identified after aquablation than HoLEP procedures. Histopathologic assessment of tissue after aquablation is feasible and may lead to the diagnosis of clinically significant iPCa. Therefore, histopathologic examination of the aquablation resective tissue should not be omitted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Minimally Invasive and Robotic Urology, Augusta Hospital Bochum, Witten/Herdecke University, Bochum, Germany.
- Institute for Pathology and Cytology, Augusta Hospital Bochum, Bochum, Germany.
- Department of Urology, Goldstadt Privatklinik, Pforzheim, Germany.
Zitieren
APA
Gloger, S., Paulics, L., Philippou, C., Philippou, S., Witt, J. H., & Ubrig, B. (2024). Perioperative Rates of Incidental Prostate Cancer after Aquablation and Holmium Laser Enucleation of the Prostate. Urologia Internationalis. https://doi.org/10.1159/000539014
Vancouver
Gloger S, Paulics L, Philippou C, Philippou S, Witt JH, Ubrig B. Perioperative Rates of Incidental Prostate Cancer after Aquablation and Holmium Laser Enucleation of the Prostate. Urologia Internationalis. 2024. doi:10.1159/000539014
BibTeX
@article{Gloger2024,
author = {Gloger, Simon and Paulics, Laszlo and Philippou, Christos and Philippou, Stathis and Witt, Joern H and Ubrig, Burkhard},
title = {Perioperative Rates of Incidental Prostate Cancer after Aquablation and Holmium Laser Enucleation of the Prostate},
journal = {Urologia Internationalis},
year = {2024},
doi = {10.1159/000539014}
}
EUVIMED